Cerus Corp (CERS.OQ) Quote| Reuters.com
Edition:
United States

Cerus Corp (CERS.OQ)

CERS.OQ on NASDAQ Stock Exchange Global Market

6.25USD
4:00pm EDT
Change (% chg)

$0.26 (+4.34%)
Prev Close
$5.99
Open
$6.03
Day's High
$6.33
Day's Low
$6.02
Volume
244,176
Avg. Vol
260,661
52-wk High
$6.88
52-wk Low
$4.28

CERS.OQ

Chart for CERS.OQ

About

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to... (more)

Overall

Beta: 1.83
Market Cap(Mil.): $609.25
Shares Outstanding(Mil.): 101.71
Dividend: --
Yield (%): --

Financials

  CERS.OQ Industry Sector
P/E (TTM): -- 41.28 34.69
EPS (TTM): -0.65 -- --
ROI: -56.10 11.63 14.13
ROE: -65.41 13.67 15.35

BRIEF-Cerus Corp says Health Canada has approved Intercept blood system for plasma

* Says health canada has approved intercept blood system for plasma Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 23 2016

BRIEF-Cerus Corp reports Q1 loss per share $0.17

* Q1 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 03 2016

Competitors

  Price Chg
Terumo Corp (4543.T) ¥4,395 +50.00
Grifols SA (GRLS.MC) €19.67 +0.73
Grifols SA (GRLSbn.MC) €14.35 +0.30

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$104.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.